Market Cap | 2.22B | P/E | 18.36 | EPS this Y | - | Ern Qtrly Grth | - |
Income | 16.18B | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -2.00% |
Sales | 218.22B | PEG | - | EPS past 5Y | - | 200D Avg Chg | 3.00% |
Dividend | 466.00% | Price/Book | 0.01 | EPS next 5Y | - | 52W High Chg | -9.00% |
Recommedations | - | Quick Ratio | 2.42 | Shares Outstanding | 167.79M | 52W Low Chg | 32.00% |
Insider Own | - | ROA | 6.00% | Shares Float | 76.86M | Beta | 0.01 |
Inst Own | 0.12% | ROE | 9.72% | Shares Shorted/Prior | -/- | Price | 13.22 |
Gross Margin | 50.74% | Profit Margin | 7.41% | Avg. Volume | 3,220 | Target Price | - |
Oper. Margin | 5.75% | Earnings Date | May 13 | Volume | 5,729 | Change | 0.99% |
Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.